Oklahoma Senate Bill SJR53

Oklahoma 2026 Regular Session

• Introduced: 4/23/26
• Refer: 4/27/26
• Report Pass: 4/27/26
• Engrossed: 5/5/26
• Refer: 5/6/26
• Report Pass: 5/6/26
• Enrolled: 5/14/26
• Passed: 5/29/26

Caption

Joint resolution; approving certain proposed permanent rules of the Oklahoma Medical Marijuana Authority.

Summary

SJR53 is a joint resolution that approves a package of permanent rules adopted by the Oklahoma Medical Marijuana Authority (OMMA). The resolution specifically lists the OMMA rules being approved, covering multiple sections of the Oklahoma Administrative Code, and it does not itself create new substantive medical marijuana policy. Instead, it serves as the Legislature’s formal approval of the agency’s major rules under Oklahoma law. By approving these rules, the resolution allows the cited OMMA regulations to take effect and remain in force as permanent rules. The measure also directs the Secretary of State to distribute copies of the resolution to the Governor and the editor of the Oklahoma Register, which is part of the administrative process for rule publication and notice. The bill’s practical impact is therefore on the regulatory framework governing Oklahoma’s medical marijuana program, including licensing, compliance, packaging, and other operational requirements addressed in the approved rule set.

Impact

SJR53 affects state law by giving legislative approval to OMMA’s major permanent rules under Title 75, Section 308 and the major-rule provisions in Title 75, Section 250.3. It does not amend the underlying medical marijuana statutes, but it validates and activates the agency’s rulemaking across the listed OAC provisions, thereby shaping how the medical marijuana program is administered and enforced for licensees, patients, and other regulated parties.

Sentiment

The overall sentiment appears generally favorable or at least procedurally supportive, as the resolution advanced through both chambers and passed the Senate and House by comfortable margins. The committee votes were narrower, especially in the Senate Administrative Rules Committee, suggesting some reservations about the rule package, but the full chamber votes indicate broad support for allowing the OMMA rules to proceed. The discussion transcript also suggests the bill was treated as a practical question about the consequences of rejecting the rules rather than as a broader policy fight.

Contention

The main point of contention was whether approving the OMMA rules would affect current practices, with at least one question raised about what would happen if the resolution failed and whether it would disrupt existing operations, including prepackaging-related practices. That indicates concern from some members about the regulatory impact on current medical marijuana businesses and compliance obligations. The committee vote split in the Senate, 5-4, also suggests some disagreement over the scope or content of the rule package, even though the final floor votes were much more decisive.